Cleared Traditional

K140868 - STRYKER KWIC NEEDLE

K140868 is an FDA 510(k) clearance for STRYKER KWIC NEEDLE, manufactured by Orthovita, Inc.. The device is a Class 2 Neurology device with product code HAW cleared through the Traditional 510(k) pathway after a 63-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2014
Decision
63d
Days
Class 2
Risk

K140868 is an FDA 510(k) clearance for the STRYKER KWIC NEEDLE. Classified as Neurological Stereotaxic Instrument (product code HAW), Class II - Special Controls.

Submitted by Orthovita, Inc. (Malvern, US). The FDA issued a Cleared decision on June 5, 2014 after a review of 63 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.4560 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Orthovita, Inc. devices

FDA 510(k) Submission Details - K140868

510(k) Number K140868 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 03, 2014
Decision Date June 05, 2014
Days to Decision 63 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
85d faster than avg
Panel avg: 148d · This submission: 63d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HAW Device Classification - Class 2, Special Controls

Product Code HAW Neurological Stereotaxic Instrument
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.4560
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - HAW Neurological Stereotaxic Instrument

All 357
Devices cleared under the same product code (HAW) and FDA review panel - the closest regulatory comparables to K140868.
V-GUIDE FOR VENTRICULOSTOMIES
K141559 · Arc Surgical, LLC · Feb 2015
NAVIGABLE BRAIN BIOPSY CANNULA SET
K140705 · Izi Medical Products · Dec 2014
STEALTHSTATION S7 / I7 / FUSION NAVIGATION SYSTEMS, AXIEM NAVIGATION SYSTEM
K133444 · Medtronic Navigation, Inc. · Jul 2014
NEUROMATE FRAMELESS GEN II
K132755 · Renishaw Mayfield Sarl · Apr 2014
MICROTABLE SYSTEM
K132611 · Fred Haer Company, Inc. · Mar 2014
CRANIAL MAP NEURO
K131214 · Stryker Corporate · Oct 2013